
$24 million funding to accelerate synthetic biology research
Evonetix has completed a $24 million financing round, extending its total series B funding to over $54 million. The fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round. The investment will enable the continued development… Read More






